To learn more about Takeda’s pivotal study for Hunter syndrome and cognitive impairment please visit: Huntersyndromeupdates.com
C-ANPROM/INT//2174 April 2020
Huntersyndrome.info is intended for an international Healthcare Professional audience outside of the USA and UK, and has been produced by Takeda Pharmaceutical Company Limited. The website has been developed in accordance with industry and legal standards to provide information for healthcare professionals about Hunter syndrome health topics. Takeda makes every reasonable effort to include accurate and current information. However, the information provided on the website is not exhaustive.
All patient images on this website are used with permission, and cannot be copied or reused in any form.
Copyright 2020 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda Logo are trademarks of Takeda Pharmaceutical Company Limited.
